JP2015521041A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015521041A5 JP2015521041A5 JP2015511948A JP2015511948A JP2015521041A5 JP 2015521041 A5 JP2015521041 A5 JP 2015521041A5 JP 2015511948 A JP2015511948 A JP 2015511948A JP 2015511948 A JP2015511948 A JP 2015511948A JP 2015521041 A5 JP2015521041 A5 JP 2015521041A5
- Authority
- JP
- Japan
- Prior art keywords
- pkn3
- inhibitor
- vegfr1
- suffering
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101000691455 Homo sapiens Serine/threonine-protein kinase N3 Proteins 0.000 claims 2
- 101000851018 Homo sapiens Vascular endothelial growth factor receptor 1 Proteins 0.000 claims 2
- 102100026219 Serine/threonine-protein kinase N3 Human genes 0.000 claims 2
- 102100033178 Vascular endothelial growth factor receptor 1 Human genes 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12003888 | 2012-05-16 | ||
| EP12003888.0 | 2012-05-16 | ||
| PCT/EP2013/001441 WO2013170960A1 (en) | 2012-05-16 | 2013-05-15 | Use of vegfr1 as a biomarker for pkn3 inhibitor administration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015521041A JP2015521041A (ja) | 2015-07-27 |
| JP2015521041A5 true JP2015521041A5 (enExample) | 2016-07-07 |
Family
ID=48446240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015511948A Pending JP2015521041A (ja) | 2012-05-16 | 2013-05-15 | Ｐｋｎ３阻害剤投与のためのバイオマーカーとしてのｖｅｇｆｒ１の使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US9133515B2 (enExample) |
| EP (1) | EP2849771A1 (enExample) |
| JP (1) | JP2015521041A (enExample) |
| WO (1) | WO2013170960A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016083623A1 (en) * | 2014-11-28 | 2016-06-02 | Silence Therapeutics Gmbh | Means for the treatment of pre-eclampsia |
| AU2017368050A1 (en) | 2016-11-29 | 2019-06-20 | Puretech Lyt, Inc. | Exosomes for delivery of therapeutic agents |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR970002255B1 (ko) | 1990-06-11 | 1997-02-26 | 넥스스타 파아마슈티컬드, 인크. | 핵산 리간드 |
| US20040220128A1 (en) * | 1995-10-26 | 2004-11-04 | Sirna Therapeutics, Inc. | Nucleic acid based modulation of female reproductive diseases and conditions |
| JP2001504448A (ja) | 1996-08-30 | 2001-04-03 | フュルステ，イェンス，ペーター | 核酸の鏡面対称選択および進化 |
| US5849902A (en) | 1996-09-26 | 1998-12-15 | Oligos Etc. Inc. | Three component chimeric antisense oligonucleotides |
| US6958239B2 (en) | 1996-11-21 | 2005-10-25 | Oligos Etc Inc. | Three component chimeric antisense oligonucleotides |
| DE19742706B4 (de) | 1997-09-26 | 2013-07-25 | Pieris Proteolab Ag | Lipocalinmuteine |
| DE19956568A1 (de) | 1999-01-30 | 2000-08-17 | Roland Kreutzer | Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens |
| EP1309726B2 (en) | 2000-03-30 | 2018-10-03 | Whitehead Institute For Biomedical Research | Rna sequence-specific mediators of rna interference |
| CN1674929B (zh) | 2002-08-14 | 2013-07-17 | 赛伦斯治疗公司 | 蛋白激酶Nβ的应用 |
| CN101490253A (zh) | 2006-07-21 | 2009-07-22 | 赛伦斯治疗公司 | 用于抑制蛋白激酶3表达的方法 |
-
2013
- 2013-05-15 JP JP2015511948A patent/JP2015521041A/ja active Pending
- 2013-05-15 WO PCT/EP2013/001441 patent/WO2013170960A1/en not_active Ceased
- 2013-05-15 EP EP13723000.9A patent/EP2849771A1/en not_active Withdrawn
- 2013-05-15 US US13/894,650 patent/US9133515B2/en not_active Expired - Fee Related
-
2015
- 2015-08-28 US US14/838,431 patent/US20150368650A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2020510I1 (lt) | Pakeistieji 4-fenil-piridinai, skirti su NK-receptoriumi susijusių ligų gydymui | |
| CY1122796T1 (el) | Βελτιωμενες φαρμακοτεχνικες μορφες αδενοϊων | |
| EP2760371A4 (en) | VENTRICULAR TRANSCATHETER RECONSTRUCTION STRUCTURES, METHODS AND SYSTEMS FOR THE TREATMENT OF CONGESTIVE HEART FAILURE AND OTHER SUFFERING | |
| LT2945642T (lt) | Faktoriaus 1 baltymas, skirtas naudoti ligų gydymui arba prevencijai | |
| JP2015513557A5 (enExample) | ||
| LT3206716T (lt) | Kanabinoidų panaudojimas atoninių traukulių gydymui, esant lennox-gastaut' sindromui | |
| HK1223795A1 (zh) | 拉喹莫德响应性的基因表达生物标志物 | |
| HUE039857T2 (hu) | Fúziós fehérjék metabolikus rendellenességek kezelésére | |
| IL231228A0 (en) | Bicyclic heterocycle derivatives for the treatmen t of pulmonary arterial hypertension | |
| IL231591A0 (en) | Converted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases | |
| JP2015520667A5 (enExample) | ||
| HUE049323T2 (hu) | Hízósejt-stabilizálók tüdõbetegség kezelésére | |
| ZA201403549B (en) | Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation | |
| WO2012112315A3 (en) | Methods for diagnosis of kawasaki disease | |
| EA201500997A1 (ru) | Терапевтические применения эмпаглифлозина | |
| HUE045724T2 (hu) | GRPR antagonisták GRPR-pozitív rák kimutatására, diagnózisára és kezelésére | |
| EA201590359A1 (ru) | Лечение ревматоидного артрита | |
| CY2020015I1 (el) | Σικλεσονιδη για τη θεραπεια της νοσου των αεραγωγων σε αλογα | |
| EP2994134A4 (en) | Methods of administering dantrolene for the acute treatment of cardiac arrhythmias | |
| HUE053229T2 (hu) | FK506 alkalmazása pulmonális artériás hipertenzió kezelésére | |
| HUE043419T2 (hu) | Vegyületek remielinizációs blokk kezelésére HERV-W borítékfehérje expresszióval járó betegségekben | |
| JP2015521041A5 (enExample) | ||
| BR112017021413A2 (pt) | anticorpos anti-flt-1 no tratamento da displasia broncopulmonar. | |
| IL262664B (en) | Compositions for treating or preventing vasomotor symptoms | |
| EA201491455A1 (ru) | ЭФФЕКТОРЫ β-АРРЕСТИНА, КОМПОЗИЦИИ, ИХ СОДЕРЖАЩИЕ, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |